Logo image
Misuse of "study drugs:" Prevalence, consequences, and implications for policy
Journal article   Open access   Peer reviewed

Misuse of "study drugs:" Prevalence, consequences, and implications for policy

S. Sussman, M. Pentz, D. Spruijt-Metz and T. Miller
Substance Abuse Treatment, Prevention, and Policy, Vol.1(1)
2006
pdf
substance abuse treatment.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Background Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy. Results Study drugs are being misused annually by approximately 4% of older teens and emerging adults. Yet, there are numerous consequences of misuse of prescription stimulants including addiction, negative reactions to high dosages, and medical complications. Policy implications include continuing to limit access to study drugs, finding more safe prescription drug alternatives, interdiction, and public education. Conclusion Much more work is needed on prescription stimulant misuse assessment, identifying the extent of the social and economic costs of misuse, monitoring and reducing access, and developing prevention and cessation education efforts.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

148 File views/ downloads
49 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.136 Autism & Development Disorders
1.136.641 ADHD
Web Of Science research areas
Substance Abuse
ESI research areas
Social Sciences, general
Logo image